English
|
中文
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & CPCEM
CAIVD
CPCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
Followed China Mobile, China Telecom Got Into Medical Field!
2022-02-11
On January 30, China Telecom Medical Health Technology Co., Ltd. was established with a registered capital of CNY 200 million.
Illumina Q4 Revenues Grow 26 Percent, Full-Year 2021 Revenues Jump 40 Percent
2022-02-11
Illumina reported after the close of the market on Thursday that its fourth quarter 2021 revenues rose 26 percent year over year, narrowly beating its own forecast last month of 25 percent growth.
Bio-Rad Reports Fourth-Quarter and Full-Year 2021 Financial Results
2022-02-11
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced financial results for the fourth quarter and year ended December 31, 2021.
The first Helicobacter pylori 23S rRNA and gyrA mutation test kit in China
2022-02-10
Jiangsu Mole Bioscience obtained the approval of the Helicobacter pylori 23S rRNA gene and gyrA gene mutation test kit (fluorescence PCR method) by NMPA. This kit is the first product in China that can simultaneously detect clarithromycin and levofloxacin resistance genes.
Roche Diagnostics Revenues Grow 29 Percent in 2021
2022-02-10
Roche on Thursday reported a 29 percent year-over-year increase in sales in its diagnostics division for full-year 2021, driven by momentum in the base business and continued demand for COVID-19 testing.
Eurofins Scientific Acquires Vietnamese Genetic Testing Firm Gentis
2022-02-10
Eurofins Scientific said on Wednesday that its subsidiary Eurofins Clinical Testing Lux Sarl has acquired Vietnamese genetic testing firm Genetic Testing Service JSC (Gentis).
U.S. Commerce Adds 33 Chinese entities to Unverified List
2022-02-09
On February 7, the U.S. Commerce Department said that it had added 33 Chinese entities to its so-called 'unverified list', which requires U.S. exporters to go through more procedures before shipping goods to the entities.
Qiagen Q4 Revenues Grow 2 Percent
2022-02-09
Qiagen reported after the close of the market on Tuesday that its fourth quarter revenues grew 2 percent year over year, beating previous guidance and analyst estimates on the top and bottom line.
Element Biosciences Acquires Loop Genomics
2022-02-09
DNA sequencing firm Element Biosciences said on Tuesday that it has acquired Loop Genomics for an undisclosed amount.
Wondfo Biotech Completed the Acquisition of 100% Equity of Shenzhen Tisenc Medical Devices
2022-02-08
On January 29, Shenzhen Tisenc Medical Devices Co., Ltd. underwent an industrial and commercial change. All the original shareholders withdrew, and WONDFO BIOTECH (300482) was newly added, holding 100% of the shares.
Hologic Fiscal Q1 Revenues Fall 9 Percent as COVID-19 Assay Sales Decline
2022-02-08
Hologic reported after the close of the market on Wednesday that revenues for its first quarter of fiscal year 2022 decreased 9 percent year over year, driven by lower sales of COVID-19 assays.
BD Board of Directors Approves embecta Spinoff and Declares Distribution of embecta Stock
2022-02-08
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its board of directors has approved the planned spinoff of its diabetes care business, which will be known as Embecta Corp.
The COVID-19 Antigen Rapid Test Self-testing Products from JOINSTART Get CE certifications
2022-02-07
The “COVID-19 Antigen Rapid Test – Anterior Nasal Swab” and the “COVID-19 Antigen Rapid Test (Colloidal Gold) – Saliva” developed independently by JOINSTAR Biomedical Technology Co., Ltd obtained the EU CE certification for self-testing on January 20th and February 2nd, issued by the CE 1434.
Becton Dickinson Acquires Spanish Clinical Flow Cytometry Firm Cytognos
2022-02-07
Becton Dickinson said on Tuesday that it has acquired Cytognos, a privately held developer of flow cytometry-based tests for hematologic cancer and blood diseases, from its parent firm Vitros.
Medix Biochemica expands its molecular diagnostics business through the acquisition of myPOLS Biotec
2022-02-07
Medix Biochemica has acquired 100 percent of the shares of myPOLS Biotec GmbH, a German manufacturer of innovative and high-quality raw materials in molecular diagnostics.
Total:
3546
Pages:
237
First
Prev
1
..
150
151
152
153
154
155
156
..
237
Next
End